De Santis M - Search Results

1

First-line treatment of metastatic disease: cisplatin-ineligible patients.

Cathomas R, De Santis M, Galsky MD. Cathomas R, et al. Among authors: de santis m. Hematol Oncol Clin North Am. 2015 Apr;29(2):329-40, x. doi: 10.1016/j.hoc.2014.10.006. Epub 2014 Dec 15. Hematol Oncol Clin North Am. 2015. PMID: 25836938 Review.

2

Docetaxel/cisplatin as first-line chemotherapy in patients with head and neck carcinoma: a phase II trial.

Baur M, Kienzer HR, Schweiger J, DeSantis M, Gerber E, Pont J, Hudec M, Schratter-Sehn AU, Wicke W, Dittrich C. Baur M, et al. Cancer. 2002 Jun 1;94(11):2953-8. doi: 10.1002/cncr.10574. Cancer. 2002. PMID: 12115384 Free article. Clinical Trial.

3

Effective salvage therapy with carboplatin/mitomycin C in metastatic breast cancer.

Baur M, Kienzer H, DeSantis M, Postner G, Pont J, Hudec M, Dittrich C. Baur M, et al. Onkologie. 2002 Jun;25(3):249-54. doi: 10.1159/000064318. Onkologie. 2002. PMID: 12119459 Clinical Trial.

4

New developments in first- and second-line chemotherapy for transitional cell, squamous cell and adenocarcinoma of the bladder.

De Santis M, Bachner M. De Santis M, et al. Curr Opin Urol. 2007 Sep;17(5):363-8. doi: 10.1097/MOU.0b013e3282c4b0cb. Curr Opin Urol. 2007. PMID: 17762632 Review.

5

Second-line therapy in bladder cancer.

Bachner M, De Santis M. Bachner M, et al. Among authors: de santis m. Curr Opin Urol. 2009 Sep;19(5):533-9. doi: 10.1097/MOU.0b013e32832eb473. Curr Opin Urol. 2009. PMID: 19550334 Review.

6

Randomized phase II/III trial assessing gemcitabine/ carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer "unfit" for cisplatin-based chemotherapy: phase II--results of EORTC study 30986.

De Santis M, Bellmunt J, Mead G, Kerst JM, Leahy M, Maroto P, Skoneczna I, Marreaud S, de Wit R, Sylvester R. De Santis M, et al. Among authors: de wit r. J Clin Oncol. 2009 Nov 20;27(33):5634-9. doi: 10.1200/JCO.2008.21.4924. Epub 2009 Sep 28. J Clin Oncol. 2009. PMID: 19786668 Free PMC article. Clinical Trial.

7

Interdisciplinary evidence-based recommendations for the follow-up of testicular cancer patients: a joint effort.

Cathomas R, Helbling D, Stenner F, Rothermundt C, Rentsch C, Shahin O, Seifert HH, Zaugg K, Lorch A, Mayer F, Beyer J, De Santis M, Gillessen S. Cathomas R, et al. Among authors: de santis m. Swiss Med Wkly. 2010 Jun 26;140(25-26):356-69. doi: 10.4414/smw.2010.12993. Swiss Med Wkly. 2010. PMID: 20544409 Free article. Review.

8

Interdisciplinary evidence-based recommendations for the follow-up of testicular germ cell cancer patients.

Cathomas R, Hartmann M, Krege S, Souchon R, Lorch A, Mayer F, De Santis M, Gillessen S; interdisziplinäre Arbeitsgruppe Hodentumore. Cathomas R, et al. Among authors: de santis m. Onkologie. 2011;34(1-2):59-64. doi: 10.1159/000323346. Epub 2011 Jan 17. Onkologie. 2011. PMID: 21346388 Review.

9

Interdisciplinary evidence-based recommendations for the follow-up of early stage seminomatous testicular germ cell cancer patients.

Souchon R, Hartmann M, Krege S, Lorch A, Mayer F, De Santis M, Gillessen S, Beyer J, Cathomas R. Souchon R, et al. Among authors: de santis m. Strahlenther Onkol. 2011 Mar;187(3):158-66. doi: 10.1007/s00066-010-2227-x. Epub 2011 Feb 21. Strahlenther Onkol. 2011. PMID: 21347634

10

[Follow-up of testicular germ cell cancer patients: interdisciplinary evidence-based recommendations].

Hartmann M, Krege S, Souchon R, De Santis M, Gillessen S, Cathomas R; Interdisziplinäre Arbeitsgruppe Hodentumore. Hartmann M, et al. Among authors: de santis m. Urologe A. 2011 Jul;50(7):830-5. doi: 10.1007/s00120-011-2556-0. Urologe A. 2011. PMID: 21503662 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,057 results

Search Page